Haemonetics (HAE) Return on Capital Employed (2010 - 2026)

Haemonetics' Return on Capital Employed history runs 17 years deep, the most recent figure standing at 7.25% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 434.0% year-over-year to 7.25%; the TTM figure through Mar 2026 stood at 7.25% (down 434.0% YoY), while the FY2026 annual figure was 7.32%, down 539.0% from the prior year.
• Return on Capital Employed was 7.25% for Q1 2026 at Haemonetics, down from 13.03% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 13.03% in Q4 2025 to a low of 2.76% in Q1 2022.
• Historically, Return on Capital Employed has averaged 8.83% across 5 years, with a median of 8.6% in 2022.
• Biggest YoY gain for Return on Capital Employed was 575 bps in 2022; the steepest drop was 890 bps in 2022.
• A 5-year view of Return on Capital Employed shows it stood at 8.51% in 2022, then grew by 8 bps to 9.23% in 2023, then retreated by 14 bps to 7.93% in 2024, then surged by 64 bps to 13.03% in 2025, then plunged by 44 bps to 7.25% in 2026.
• The last three Return on Capital Employed figures came in at 7.25% (Q1 2026), 13.03% (Q4 2025), and 12.75% (Q3 2025), per Business Quant data.